SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-16-461006
Filing Date
2016-02-12
Accepted
2016-02-12 06:10:31
Documents
2
Group Members
ARNOLD L. ORONSKYGILBERT H. KLIMANHARVEY B. CASHINTERWEST INVESTORS VII, LPINTERWEST MANAGEMENT PARTNERS VII, LLCINTERWEST VENTURE MANAGEMENT COPHILIP T. GIANOSW. STEPHEN HOLMES III

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d126054dsc13ga.htm SC 13G/A 147831
2 EX-99.A d126054dex99a.htm EX-99.A 8461
  Complete submission text file 0001193125-16-461006.txt   157958
Mailing Address
Business Address 3000 SAND HILL RD 3-255 MENLO PARK CA 94025 6508548585
INTERWEST PARTNERS VII L P (Filed by) CIK: 0001081736 (see all company filings)

IRS No.: 943319533 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Subject) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88403 | Film No.: 161414020
SIC: 2834 Pharmaceutical Preparations